The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Katasonov A.B.
Curcumin as an ajuvant treatment of depression: mechanisms of action and application prospects
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(2): 125‑131
Views: 48571
Downloaded: 626
To cite this article:
Katasonov AB. Curcumin as an ajuvant treatment of depression: mechanisms of action and application prospects. S.S. Korsakov Journal of Neurology and Psychiatry.
2020;120(2):125‑131. (In Russ.)
https://doi.org/10.17116/jnevro2020120021125
Curcumin, a natural compound found in the rhizomes of turmeric, has a pronounced anti-inflammatory activity. Rodent models of depression show that this activity is similar to the effect of antidepressants (AD). Experimental data indicate that this activity may be related to the effect of curcumin on the monoamine cycle, oxidative and nitrosative stress, neurogenesis, hypothalamic-pituitary-adrenal, and immune systems. A number of meta-analyzes indicate the effectiveness of the combined use of curcumin with antidepressants in the treatment of depression. The mechanism of action of curcumin, as well as the prospects for its further use are considered.
Keywords:
Authors:
Katasonov A.B.
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.